サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463684

中南米の新生児スクリーニング：2030年までの市場予測 - 地域分析 - 製品タイプ、技術、検査タイプ、エンドユーザー別

South & Central America Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日: | 発行: The Insight Partners | ページ情報: 英文 85 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.41円
中南米の新生児スクリーニング：2030年までの市場予測 - 地域分析 - 製品タイプ、技術、検査タイプ、エンドユーザー別
出版日: 2024年02月07日
発行: The Insight Partners
ページ情報: 英文 85 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の新生児スクリーニング市場は、2022年に5,808万米ドルと評価され、2030年には1億64万米ドルに達すると予測され、2022年から2030年までのCAGRは7.1%で成長すると予測されています。

新生児の遺伝子スクリーニングが中南米の新生児スクリーニング市場を後押し

病状の遺伝的原因に関する知識の深まりとヘルスケア技術の進歩に伴い、新生児の包括的な遺伝子スクリーニングの需要が高まっています。その結果、新生児スクリーニング市場の企業は、革新的で費用対効果の高いスクリーニング・ソリューションを開発しています。YescartaとZyntegloは、大細胞型B細胞リンパ腫とβ-サラセミアに対する認可された遺伝子治療の2つの例です。さらに、出生時に疾患に対する遺伝的素因を特定する能力を付与する技術の出現は、個別化ヘルスケアへの道を開き、精密医療という広範な傾向と一致します。

妊娠中の遺伝性疾患のスクリーニングは、妊娠に関連する問題の早期発見にも重点を置いています。次世代シーケンサーは、すべての染色体における異数体（ダウン症候群やトリソミー21など）や部分的な染色体異常（重複や欠失）の検出において95％以上の感度で新生児の出生前スクリーニングを支援します。蛍光in-situハイブリダイゼーション（FISH）は、鎌状赤血球貧血のような単発性疾患を検出するために使用されます。母体血漿を用いた無細胞胎児DNAアプローチのような非侵襲的手順は、遺伝子検査における最近の進歩です。胚DNAはその大きさの違いから母体DNA片と区別することができます。蛍光プローブを用いたリアルタイムPCR、ショットガンシーケンス（SolexaまたはIllumina）、あるいは巨大なターゲットパラレルシーケンスを用いて、胎児の病状に関連するDNAを調べることができます。これにより、この種の遺伝子スクリーニングがさらに研究されれば、医師は特定の薬理療法（薬理遺伝学）による早期の分子介入を行ったり、細胞、組織、臓器を物理的、化学的に変化させたりすることができるようになります。このように、乳児の遺伝性疾患スクリーニング方法の進歩は、新生児スクリーニング市場全体にとって計り知れない可能性を秘めています。

中南米の新生児スクリーニング市場概要

中南米の新生児スクリーニング市場は、ブラジル、アルゼンチン、その他中南米に区分されます。中南米は、地理的地域、人口統計、経済、社会、民族、新興経済諸国、ヘルスケアシステムなど多様な20カ国からなる地域です。ブラジル、アルゼンチン、その他の中南米諸国は、高所得国に比べて新生児スクリーニングプログラムの数が比較的少ないです。これは主に、経済的、技術的、物流的な制約や、この地域の各国の社会的、文化的、政治的背景の違いによるものです。連邦政府の新生児スクリーニング（NBS）プログラムには、現在6つの疾患が含まれている：先天性甲状腺機能低下症、嚢胞性線維症、ガラクトース血症検査、ビオチニダーゼ欠乏症、先天性副腎過形成です。さらに、この地域の新生児スクリーニング・プログラムと能力は継続的に向上しています。チリ、コスタリカ、キューバ、ウルグアイの長年にわたるNBSプログラムは、新生児の99％以上をカバーしています。ブラジル、メキシコ、アルゼンチンのプログラムはスクリーニング・パネルを増やしているが、教育、フォローアップ、法整備、管理の改善が必要です。

ブラジルは2001年に全国的なNBSプログラムを開始し、新生児の80％以上をカバーするリファレンスセンターを設置しました。このプログラムには6つの主な疾患が含まれる：フェニルケトン尿症、先天性甲状腺機能低下症、ヘモグロビノパチー、嚢胞性線維症、先天性副腎過形成、ビオチニダーゼ欠乏症です。ブラジルの全国新生児スクリーニング・プログラムは、今後数年間で出生児の100％を達成することを目標としています。また、タンデム質量分析計（TMS）スクリーニングによる他の代謝性疾患に対する拡張NBS（ENBS）も、いくつかの州で実施されています。2021年6月にブラジルの政府当局によって法律が可決され、2022年6月までに全州でENBSを実施することが義務付けられ、ライソゾーム病、免疫不全症、脊髄性筋萎縮症を含むプログラムへの段階的な拡大が予定されています。このように、同国ではここ数年、新しいプログラムの実施、医療ヘルスケア適用範囲の拡大、新しいNBS法の制定、疾患パネルの拡大、政府や公衆衛生当局の関与の強化などにより、著しい持続的な成長が見られています。NBS/ENBSプログラムの採用増加は、新生児の早期診断と治療を促進し、患者の健康転帰を改善する第一歩であることを証明します。

中南米の新生児スクリーニング市場の収益と2030年までの予測（金額）

中南米の新生児スクリーニング市場セグメンテーション

中南米の新生児スクリーニング市場は、製品タイプ、技術、検査タイプ、エンドユーザー、国によって区分されます。

製品タイプに基づき、中南米の新生児スクリーニング市場は試薬・アッセイキットと機器に二分されます。試薬とアッセイキットセグメントは、2022年に中南米の新生児スクリーニング市場でより大きなシェアを占めました。試薬・アッセイキット分野はDNAベースアッセイ、免疫アッセイ、酵素アッセイに細分化されます。機器セグメントは、新生児障害スクリーニング機器、パルスオキシメーター、新生児聴覚スクリーニング機器、その他の機器に細分化されます。

技術面では、中南米の新生児スクリーニング市場はタンデム質量分析（TMS）、分子アッセイ、免疫アッセイと酵素アッセイ、パルスオキシメトリースクリーニング技術、その他の技術に分類されます。パルスオキシメトリースクリーニング技術セグメントは、2022年に南米新生児スクリーニング市場で最大のシェアを占めました。

検査タイプに基づき、中南米の新生児スクリーニング市場は、乾燥血液スポット検査、聴覚スクリーン検査、重症先天性心疾患（CCHD）検査、その他の検査タイプに分類されます。2022年の中南米の新生児スクリーニング市場シェアは、乾燥血液スポット検査分野が最大でした。

エンドユーザー別では、中南米の新生児スクリーニング市場は病院・診療所と診断研究所に区分されます。病院・診療所セグメントは2022年に中南米の新生児スクリーニング市場でより大きなシェアを占めました。

国別では、中南米の新生児スクリーニング市場は、ブラジル、アルゼンチン、その他中南米に分類されます。ブラジルは2022年に中南米の新生児スクリーニング市場を独占しました。

Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、PerkinElmer Inc、Waters Corpは、中南米の新生児スクリーニング市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の新生児スクリーニング市場：主要産業力学

  • 市場促進要因
    • 新生児スクリーニングに対する政府資金の急増
    • 先天性疾患の負担増
    • 新生児疾患の有病率の増加
  • 主な市場抑制要因
    • 新生児スクリーニングの政策と実施における統一性の欠如
  • 主な市場機会
    • 新生児の遺伝子スクリーニング
  • 今後の動向
    • スクリーニングにおける機械学習と人工知能の統合
  • 影響分析

第5章 新生児スクリーニング市場：中南米市場分析

  • 中南米の新生児スクリーニング市場収益、2022年～2030年

第6章 中南米の新生児スクリーニング市場 - 収益と2030年までの予測：製品タイプ別

  • 市場収益シェア、2022年および2030年
  • 試薬およびアッセイキット
  • 検査機器

第7章 中南米の新生児スクリーニング市場 - 収益と2030年までの予測：技術別

  • 市場収益シェア、2022年および2030年
  • タンデム質量分析（TMS）
  • 分子アッセイ
  • 免疫アッセイおよび酵素アッセイ
  • パルスオキシメトリー・スクリーニング技術
  • その他の技術

第8章 中南米の新生児スクリーニング市場 - 収益と2030年までの予測：検査タイプ別

  • 市場収益シェア、2022年および2030年
  • 乾燥血液スポット検査
  • 聴覚スクリーニング検査
  • 重症先天性心疾患（CCHD）検査
  • その他の検査タイプ

第9章 中南米の新生児スクリーニング市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院および診療所
  • 診断ラボ

第10章 中南米の新生児スクリーニング市場：国別分析

  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 中南米の新生児スクリーニング市場-業界情勢

  • 新生児スクリーニング市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Medtronic Plc

第13章 付録

図表

List Of Tables

  • Table 1. South & Central America Newborn Screening Market Segmentation
  • Table 2. South & Central America Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. South & Central America Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Brazil Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Brazil Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Brazil Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Brazil Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Argentina Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Argentina Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Argentina Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Argentina Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Argentina Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Argentina Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Rest of South & Central America Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of South & Central America Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of South & Central America Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of South & Central America Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Rest of South & Central America Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Rest of South & Central America Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 23. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 24. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. South & Central America Newborn Screening Market Segmentation, By Country
  • Figure 2. Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. South & Central America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. South & Central America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. South & Central America Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. South & Central America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in Newborn Screening Market
目次
Product Code: BMIRE00029607

The South & Central America newborn screening market was valued at US$ 58.08 million in 2022 and is expected to reach US$ 100.64 million by 2030; it is estimated to grow at a CAGR of 7.1% from 2022 to 2030.

Genetic Screening of Newborns Fuels the South & Central America Newborn Screening Market

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. Yescarta and Zynteglo are two examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

South & Central America Newborn Screening Market Overview

The newborn screening market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. South & Central America is a region comprising 20 diversified countries in terms of geographic area, demographics, economy, society, ethnicity, and developing healthcare systems. Brazil, Argentina, and other South & Central American countries receive a comparatively low number of newborn screening programs than higher-income nations. This is mainly due to the economic, technical, and logistical constraints and differences in the social, cultural, and political backgrounds of each country in the region. The federal NewBorn Screening (NBS) program currently includes six conditions: Congenital Hypothyroidism, Cystic Fibrosis, galactosemia test, biotinidase deficiency, and Congenital Adrenal Hyperplasia in the region. Moreover, the newborn screening programs and capabilities in the region are continuously improving. Longstanding NBS programs in Chile, Costa Rica, Cuba, and Uruguay cover over 99% of newborns. The programs in Brazil, Mexico, and Argentina have increased their screening panels but require education, follow-up, legislation, and management improvements.

Brazil started its nationwide NBS program in 2001 with reference centers that covered more than 80% of newborns. This program includes six main conditions: Phenylketonuria, Congenital Hypothyroidism, hemoglobinopathies, Cystic Fibrosis, Congenital Adrenal Hyperplasia, and biotinidase deficiency. The National Neonatal Screening Program in Brazil is targeting to reach 100% of live births over the next few years. The country has also implemented the Extended NBS (ENBS) for other metabolic disorders through tandem mass spectrometer (TMS) screening in a few states. A law was passed in June 2021 by the government authority of Brazil, mandating that all states implement ENBS by June 2022, with a progressive expansion of the program to include lysosomal diseases, immunodeficiencies, and spinal muscular atrophy. Thus, the country has witnessed significant and sustained growth in the last few years, owing to the implementation of new programs, a rise in medical healthcare coverage, the enactment of new NBS laws, the expansion of the disease panel, and the higher involvement of government and public health authorities. Increasing the adoption of NBS/ENBS programs promotes early diagnosis and treatment in neonates, which prove to be the first step to improving health outcomes for patients.

South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Newborn Screening Market Segmentation

The South & Central America newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the South & Central America newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger South & Central America newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the South & Central America newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest South & Central America newborn screening market share in 2022.

Based on test type, the South & Central America newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest South & Central America newborn screening market share in 2022.

By end user, the South & Central America newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger South & Central America newborn screening market share in 2022.

Based on country, the South & Central America newborn screening market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America newborn screening market in 2022.

Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, PerkinElmer Inc, and Waters Corp are some of the leading companies operating in the South & Central America newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - South & Central America Market Analysis

  • 5.1 South & Central America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 South & Central America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 South & Central America Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 South & Central America Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. South & Central America Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 South & Central America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 South & Central America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 South & Central America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: South & Central America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Newborn Screening Market - Country Analysis

  • 10.1 South & Central America Newborn Screening Market, Revenue and Forecast to 2030
    • 10.1.1 South & Central America Newborn Screening Market, by Country
      • 10.1.1.1 Brazil
        • 10.1.1.1.1 Brazil Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 Brazil: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 Brazil: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 Brazil: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 Brazil: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 Brazil: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 Brazil: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Argentina
        • 10.1.1.2.1 Argentina Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Argentina: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Argentina: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Argentina: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Argentina: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Argentina: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Argentina: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Rest of South & Central America
        • 10.1.1.3.1 Rest of South & Central America Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Rest of South & Central America: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 Rest of South & Central America: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 Rest of South & Central America: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Rest of South & Central America: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Rest of South & Central America: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Rest of South & Central America: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. South & Central America Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 PerkinElmer Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Waters Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bio-Rad Laboratories Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Masimo Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Medtronic Plc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms